Aurigene Pharmaceutical Services is a leading Contract Research, Development and Manufacturing Organization (CDMO) dedicated to providing comprehensive solutions to the pharmaceutical industry. With a strong foundation built on a legacy of accelerating innovation, the company leverages its extensive experience in drug discovery, development, and manufacturing to support clients throughout the entire lifecycle of a molecule. Aurigene's mission focuses on fostering long-term relationships through a holistic approach that expedites the journey of pharmaceutical products from laboratory to market. Offering access to a wealth of resources, knowledge, and expertise, Aurigene Pharmaceutical Services is committed to creating success for its clients.

Services include:
- Biologics
- Laboratory and Analytical Services
- Protein and Peptide
- Cell and Gene Therapy
- Regulatory Services
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Solid Dosage
- Injectables
- Non Sterile Dosage
- Packaging
- Analytical Services
- cGMP Synthesis
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Process Development
- Formulation Development
- Controlled Release
- Clinical Trial Materials
- Controlled Substances
- Cytotoxic & High Potency Compounds
- Oligonucleotides
- Orally Dispersible Tablet
- Semisolids
- ADMET
- Animal Health
- Bioavailability Studies
- Medicinal
- Custom Synthesis
- Excipients
- Lipids/Phospholipids
- Aseptic Fill-Finish
- Capsule
- Peptides
- Organic Synthesis
- Process R&D

Aurigene Pharmaceutical Services is poised to deliver innovative solutions tailored to meet the demands of the pharmaceutical sector, ensuring the success of their clients' initiatives. For more information, please visit aurigeneservices.com.